메뉴 건너뛰기




Volumn 50, Issue 12, 2012, Pages 4078-4082

Association of relapse of Clostridium difficile disease with BI/NAP1/027

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE DURATION; FEMALE; GENETIC VARIABILITY; HUMAN; INFECTION CONTROL; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; MULTIVARIATE ANALYSIS; NONHUMAN; PATIENT CARE; PRIORITY JOURNAL; RECURRENT INFECTION; REINFECTION; RISK ASSESSMENT; UNIVARIATE ANALYSIS; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 84869222966     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02291-12     Document Type: Article
Times cited : (113)

References (27)
  • 1
    • 46249102186 scopus 로고    scopus 로고
    • Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin
    • DOI 10.1086/588293
    • Al-Nassir WN, et al. 2008. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin. Clin. Infect. Dis. 47:56-62. (Pubitemid 351920588)
    • (2008) Clinical Infectious Diseases , vol.47 , Issue.1 , pp. 56-62
    • Al-Nassir, W.N.1    Sethi, A.K.2    Nerandzic, M.M.3    Bobulsky, G.S.4    Jump, R.L.P.5    Donskey, C.J.6
  • 2
  • 4
    • 67949102239 scopus 로고    scopus 로고
    • Clostridium difficile strain NAP-1 is not associated with severe disease in a nonepidemic setting
    • Cloud J, Noddin L, Pressman A, Hu M, Kelly C. 2009. Clostridium difficile strain NAP-1 is not associated with severe disease in a nonepidemic setting. Clin. Gastroenterol. Hepatol. 7:868-873.e2.
    • (2009) Clin. Gastroenterol. Hepatol. , vol.7
    • Cloud, J.1    Noddin, L.2    Pressman, A.3    Hu, M.4    Kelly, C.5
  • 6
    • 79956275289 scopus 로고    scopus 로고
    • Clinical Clostridium difficile: Clonality and pathogenicity locus diversity
    • doi:10.1371/journal.pone.0019993
    • Dingle KE, et al. 2011. Clinical Clostridium difficile: clonality and pathogenicity locus diversity. PLoS One 6:e19993. doi:10.1371/journal.pone. 0019993.
    • (2011) PLoS One , vol.6
    • Dingle, K.E.1
  • 7
    • 84555188050 scopus 로고    scopus 로고
    • Clostridium difficile mixed infection and reinfection
    • Eyre DW, et al. 2012. Clostridium difficile mixed infection and reinfection. J. Clin. Microbiol. 50:142-144.
    • (2012) J. Clin. Microbiol. , vol.50 , pp. 142-144
    • Eyre, D.W.1
  • 8
    • 84863661973 scopus 로고    scopus 로고
    • Relapse versus reinfection: Recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin
    • Figueroa I, et al. 2012. Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin. Clin. Infect. Dis. 55(Suppl 2):S104-S109.
    • (2012) Clin. Infect. Dis. , vol.55 , Issue.SUPPL. 2
    • Figueroa, I.1
  • 9
    • 60549090317 scopus 로고    scopus 로고
    • Antimotility agents for the treatment of Clostridium difficile infection: Is the juice worth the squeeze?
    • Gerding DN. 2009. Antimotility agents for the treatment of Clostridium difficile infection: is the juice worth the squeeze? Clin. Infect. Dis. 48:606-608.
    • (2009) Clin. Infect. Dis. , vol.48 , pp. 606-608
    • Gerding, D.N.1
  • 10
    • 77952564778 scopus 로고    scopus 로고
    • Economic healthcare costs of Clostridium difficile infection: A systematic review
    • Ghantoji SS, Sail K, Lairson DR, DuPont HL, Garey KW. 2010. Economic healthcare costs of Clostridium difficile infection: a systematic review. J. Hosp. Infect. 74:309-318.
    • (2010) J. Hosp. Infect. , vol.74 , pp. 309-318
    • Ghantoji, S.S.1    Sail, K.2    Lairson, D.R.3    DuPont, H.L.4    Garey, K.W.5
  • 11
    • 67349239352 scopus 로고    scopus 로고
    • Recurrent Clostridium difficile infection: A review of risk factors, treatments, and outcomes
    • doi:10.1016/j.jinf.2009.03.010
    • Johnson S. 2009. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. J. Infect. 58:403-410. doi:10.1016/j.jinf.2009.03.010.
    • (2009) J. Infect. , vol.58 , pp. 403-410
    • Johnson, S.1
  • 13
    • 80054730409 scopus 로고    scopus 로고
    • Relapse versus reinfection: Surveillance of Clostridium difficile infection
    • Kamboj M, et al. 2011. Relapse versus reinfection: surveillance of Clostridium difficile infection. Clin. Infect. Dis. 53:1003-1006.
    • (2011) Clin. Infect. Dis. , vol.53 , pp. 1003-1006
    • Kamboj, M.1
  • 15
    • 0035915688 scopus 로고    scopus 로고
    • Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea
    • DOI 10.1016/S0140-6736(00)03592-3
    • Kyne L, Warny M, Qamar A, Kelly CP. 2001. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet 357:189-193. doi:10.1016/S0140-6736(00)03592-3. (Pubitemid 32108091)
    • (2001) Lancet , vol.357 , Issue.9251 , pp. 189-193
    • Kyne, L.1    Warny, M.2    Qamar, A.3    Kelly, C.P.4
  • 16
    • 79551527297 scopus 로고    scopus 로고
    • Fidaxomicin versus vancomycin for Clostridium difficile infection
    • Louie TJ, et al. 2011. Fidaxomicin versus vancomycin for Clostridium difficile infection. N. Engl. J. Med. 364:422-431.
    • (2011) N. Engl. J. Med. , vol.364 , pp. 422-431
    • Louie, T.J.1
  • 18
    • 75649095225 scopus 로고    scopus 로고
    • Multilocus variable-number tandem-repeat analysis and multilocus sequence typing reveal genetic relationships among Clostridium difficile isolates genotyped by restriction endonuclease analysis
    • Marsh JW, et al. 2010. Multilocus variable-number tandem-repeat analysis and multilocus sequence typing reveal genetic relationships among Clostridium difficile isolates genotyped by restriction endonuclease analysis. J. Clin. Microbiol. 48:412-418.
    • (2010) J. Clin. Microbiol. , vol.48 , pp. 412-418
    • Marsh, J.W.1
  • 20
    • 0032614375 scopus 로고    scopus 로고
    • Recurrent Clostridium difficile disease: Epidemiology and clinical characteristics
    • McFarland LV, et al. 1999. Recurrent Clostridium difficile disease: epidemiology and clinical characteristics. Infect. Control Hosp. Epidemiol. 20:43-50.
    • (1999) Infect. Control Hosp. Epidemiol. , vol.20 , pp. 43-50
    • McFarland, L.V.1
  • 21
    • 46349087809 scopus 로고    scopus 로고
    • Clinical severity of Clostridium difficile PCR ribotype 027: A case-case study
    • doi:10.1371/journal.pone.0001812
    • Morgan OW, et al. 2008. Clinical severity of Clostridium difficile PCR ribotype 027: a case-case study. PLoS One 3:e1812. doi:10.1371/journal.pone. 0001812.
    • (2008) PLoS One , vol.3
    • Morgan, O.W.1
  • 25
    • 0032435128 scopus 로고    scopus 로고
    • Clostridium difficile colitis: Factors influencing treatment failure and relapse a prospective evaluation
    • DOI 10.1016/S0002-9270(98)00422-5, PII S0002927098004225
    • Nair S, Yadav D, Corpuz M, Pitchumoni CS. 1998. Clostridium difficile colitis: factors influencing treatment failure and relapse-a prospective evaluation. Am. J. Gastroenterol. 93:1873-1876. (Pubitemid 29071697)
    • (1998) American Journal of Gastroenterology , vol.93 , Issue.10 , pp. 1873-1876
    • Nair, S.1    Yadav, D.2    Corpuz, M.3    Pitchumoni, C.S.4
  • 26
    • 84863923754 scopus 로고    scopus 로고
    • Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain
    • Petrella LA, et al. 2012. Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain. Clin. Infect. Dis. 55:351-357.
    • (2012) Clin. Infect. Dis. , vol.55 , pp. 351-357
    • Petrella, L.A.1
  • 27
    • 85027958654 scopus 로고    scopus 로고
    • Treatment of refractory and recurrent Clostridium difficile infection
    • Surawicz CM, Alexander J. 2011. Treatment of refractory and recurrent Clostridium difficile infection. Nat. Rev. Gastroenterol. Hepatol. 8:330-339.
    • (2011) Nat. Rev. Gastroenterol. Hepatol. , vol.8 , pp. 330-339
    • Surawicz, C.M.1    Alexander, J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.